BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31381339)

  • 1. Enantioselective Synthesis of Homoisoflavanones by Asymmetric Transfer Hydrogenation and Their Biological Evaluation for Antiangiogenic Activity.
    Heo M; Lee B; Sishtla K; Fei X; Lee S; Park S; Yuan Y; Lee S; Kwon S; Lee J; Kim S; Corson TW; Seo SY
    J Org Chem; 2019 Aug; 84(16):9995-10011. PubMed ID: 31381339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Biological Evaluation of Novel Homoisoflavonoids for Retinal Neovascularization.
    Basavarajappa HD; Lee B; Lee H; Sulaiman RS; An H; Magaña C; Shadmand M; Vayl A; Rajashekhar G; Kim EY; Suh YG; Lee K; Seo SY; Corson TW
    J Med Chem; 2015 Jun; 58(12):5015-5027. PubMed ID: 26035340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and mechanistic studies of a novel homoisoflavanone inhibitor of endothelial cell growth.
    Basavarajappa HD; Lee B; Fei X; Lim D; Callaghan B; Mund JA; Case J; Rajashekhar G; Seo SY; Corson TW
    PLoS One; 2014; 9(4):e95694. PubMed ID: 24752613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, structure-activity relationships and biological evaluation of barbigerone analogues as anti-proliferative and anti-angiogenesis agents.
    Wang G; Wang F; Cao D; Liu Y; Zhang R; Ye H; Li X; He L; Yang Z; Ma L; Peng A; Xiang M; Wei Y; Chen L
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3158-63. PubMed ID: 24863745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of photoaffinity probes of antiangiogenic homoisoflavonoids.
    Lee B; Sun W; Lee H; Basavarajappa H; Sulaiman RS; Sishtla K; Fei X; Corson TW; Seo SY
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4277-81. PubMed ID: 27481561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The first synthesis of the antiangiogenic homoisoflavanone, cremastranone.
    Lee B; Basavarajappa HD; Sulaiman RS; Fei X; Seo SY; Corson TW
    Org Biomol Chem; 2014 Oct; 12(39):7673-7. PubMed ID: 25167470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Antiangiogenic Activity of Naturally Occurring and Synthetic Homoisoflavonoids from the Hyacinthaceae ( sensu APGII).
    Schwikkard S; Whitmore H; Sishtla K; Sulaiman RS; Shetty T; Basavarajappa HD; Waller C; Alqahtani A; Frankemoelle L; Chapman A; Crouch N; Wetschnig W; Knirsch W; Andriantiana J; Mas-Claret E; Langat MK; Mulholland D; Corson TW
    J Nat Prod; 2019 May; 82(5):1227-1239. PubMed ID: 30951308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of potent and practical antiangiogenic agents inspired by cortistatin A.
    Czakó B; Kürti L; Mammoto A; Ingber DE; Corey EJ
    J Am Chem Soc; 2009 Jul; 131(25):9014-9. PubMed ID: 19469509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.
    Wang W; LeBlanc ME; Chen X; Chen P; Ji Y; Brewer M; Tian H; Spring SR; Webster KA; Li W
    Angiogenesis; 2017 Nov; 20(4):479-492. PubMed ID: 28447229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters.
    Nazarov AA; Baquié M; Nowak-Sliwinska P; Zava O; van Beijnum JR; Groessl M; Chisholm DM; Ahmadi Z; McIndoe JS; Griffioen AW; van den Bergh H; Dyson PJ
    Sci Rep; 2013; 3():1485. PubMed ID: 23508096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of nicotinamide derivative as anti-angiogenic agents.
    Choi HE; Choi JH; Lee JY; Kim JH; Kim JH; Lee JK; Kim GI; Park Y; Chi YH; Paik SH; Lee JH; Lee KT
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2083-8. PubMed ID: 23453071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenic effect of adiponectin in human primary microvascular and macrovascular endothelial cells.
    Palanisamy K; Nareshkumar RN; Sivagurunathan S; Raman R; Sulochana KN; Chidambaram S
    Microvasc Res; 2019 Mar; 122():136-145. PubMed ID: 30144414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-181a inhibits ocular neovascularization by interfering with vascular endothelial growth factor expression.
    Yang C; Tahiri H; Cai C; Gu M; Gagnon C; Hardy P
    Cardiovasc Ther; 2018 Jun; 36(3):e12329. PubMed ID: 29608244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
    Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
    PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
    Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
    Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An arylidene-thiazolidinedione derivative, GPU-4, without PPARγ activation, reduces retinal neovascularization.
    Nakamura S; Hayashi K; Takizawa H; Murase T; Tsuruma K; Shimazawa M; Kakuta H; Nagasawa H; Hara H
    Curr Neurovasc Res; 2011 Feb; 8(1):25-34. PubMed ID: 21208163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.
    Gong Y; Shao Z; Fu Z; Edin ML; Sun Y; Liegl RG; Wang Z; Liu CH; Burnim SB; Meng SS; Lih FB; SanGiovanni JP; Zeldin DC; Hellström A; Smith LEH
    EBioMedicine; 2016 Nov; 13():201-211. PubMed ID: 27720395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 Oxidase 2C Inhibition Adds to ω-3 Long-Chain Polyunsaturated Fatty Acids Protection Against Retinal and Choroidal Neovascularization.
    Gong Y; Fu Z; Edin ML; Liu CH; Wang Z; Shao Z; Fredrick TW; Saba NJ; Morss PC; Burnim SB; Meng SS; Lih FB; Lee KS; Moran EP; SanGiovanni JP; Hellström A; Hammock BD; Zeldin DC; Smith LE
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1919-27. PubMed ID: 27417579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of a polyglutamic acid-dopamine conjugate: a new antiangiogenic agent.
    Fante C; Eldar-Boock A; Satchi-Fainaro R; Osborn HM; Greco F
    J Med Chem; 2011 Jul; 54(14):5255-9. PubMed ID: 21710976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenic effects of purine inhibitors of cyclin dependent kinases.
    Liebl J; Krystof V; Vereb G; Takács L; Strnad M; Pechan P; Havlicek L; Zatloukal M; Fürst R; Vollmar AM; Zahler S
    Angiogenesis; 2011 Sep; 14(3):281-91. PubMed ID: 21487803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.